None listed
Conditions
Brief summary
This study will compare the airway pressure generated in cardiac surgical patients receiving high flow humidified nasal oxygen therapy to that generated in the same patient when receiving non-invasive ventilation via a face mask.
Interventions
Patients undergoing cardiac surgery will be invited pre-operatively to participate in this study. Participants will have pressure measurements carried out with both Optiflow trademark and facemask non-invasive ventilation (NIV). Following surgery, whilst the participant is sedated and ventilated in the Intensive Care Unit, a 10F catheter will be inserted into the nasopharynx via the nose. Once the patient has been woken and extubated a baseline airway pressure measurement will be performed while the patient breathes spontaneously on their routine oxygen therapy device e.g. standard nasal cannulae or facemask. Pressure measurements will be carried out following a random sequence for both the Optiflow trademark system and NIV delivered via a facemask. Participants will have 3 measurements performed on the Optiflow interface at 30, 40 and 50 litres per minute and 3 measurements performed on NIV at 4,6 and 8 cmH2O via a facemask. For each group, pressure measurement for each flow/pressure will be recorded over one minute of breathing using precision pressure transducer (PPT). This procedure is expected to take around 30 mins. The catheter will be removed at the end of this period.
Sponsors
Study design
Eligibility
Inclusion criteria
Consent has been obtained. Patient is over 18 years of age. Patient is to undergo cardiac surgery.
Exclusion criteria
The patient has significant nasal septum deviation. High flow nasal oxygen therapy is contraindicated. Non-invasive ventilation is contraindicated Following surgery the patient is unable to follow simple commands once awake and extubated.